Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Revenue

In the year 2025, Xvivo Perfusion AB had annual revenue of 812.17M SEK, down -1.25%. Xvivo Perfusion AB had revenue of 226.14M in the quarter ending December 31, 2025, a decrease of -0.62%.

• Revenue: 812.17M
• Revenue Growth: -1.25%
• P/S Ratio: 7.27
• Revenue / Employee: 4.10M
• Employees: 198
• Market Cap: 5.91B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	812.17M	-10.25M	-1.25%
Dec 31, 2024	822.42M	224.87M	37.63%
Dec 31, 2023	597.54M	182.25M	43.88%
Dec 31, 2022	415.29M	156.91M	60.73%
Dec 31, 2021	258.39M	78.53M	43.66%